- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04169113
Opiate Prescribing Guidelines Following Hip Arthroscopy
How Many Opiates Should be Prescribed for Pain in Patients Undergoing Hip Arthroscopy?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Perioperative pain management is an important aspect of quality patient care. Opioid pain medications are increasingly being used for pain control, with the United States writing over 250 million prescriptions for painkillers per year. Increased usage has led to unintended negative consequences for individuals and society. It is estimated that 46 people die each day from an overdose of prescription painkillers, and individual use can lead to the development of tolerance and worse treatment outcomes. Further issues arise when opioids are misused, it is estimated that nontherapeutic use has increased three fold in recent years. In the United States alone in 2006 the estimated total cost of opioid prescription misuse was $53.4 billion, of which $42 billion was attributed to lost productivity, $8.2 billion to criminal justice cost and the remainder drug abuse treatment and medical complications. The federal government has recognized this epidemic and raised a call for clinicians to more responsibly prescribe opiate pain medications
Opiate use has increased in recent years, from 2000-2010 the use of opiates in office based visits nearly doubled from 11.3% to 19.6% whereas there was no change in the prescribing of non-opioid pharmacotherapies. Further, when specifically looking at new musculoskeletal pain visits, one half resulted in pharmacologic treatment, with the prescribing of non-opioid pharmacotherapies decreasing from 38% to 29% from 2000 to 2010, respectively. The clinical use of opioids for post-operative pain control has also been linked to the opioid epidemic and risk of future abuse. Legitimate opioid use before high school graduation is independently associated with a 33% increased risk of future misuse after high school.
It has been estimated that orthopedic surgeons prescribe 7.7% of all opioids in the United States.Special attention needs to be paid to the amount of opioid pain medications orthopedic surgeons prescribe to patients after ambulatory surgery, there is considerable variability among surgeon and procedure in regards to the amount of opioids to prescribe with many patients left with excess unused medication .An analysis of 250 patients undergoing outpatient upper extremity surgery found that on average patients consumed 10 opioid pills, with 19 pills left over and a total of 4,639 pills going unused in the cohort. Leftover prescription opioids are at risk for diversion to family and friends for nonmedical use. Further studies are needed to quantify the amount of opioids to prescribe for specific orthopedic procedures to limit excess narcotic use, misuse, diversion and contribution to the opioid epidemic.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University Department of Orthopaedic Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All patients presenting to Northwestern Memorial Hospital (NMH) or to a Northwestern orthopaedic surgery faculty member's clinic undergoing hip arthroscopy
- 18 years old or greater
- Ability to read and speak English
Exclusion Criteria:
- Revision surgery
- Oncologic etiology
- Arthroscopic hip surgery that involves procedures other than labral repair, acetabuloplasty, CAM-plasty, IT band windowing, Iliopsoas lengthening
- Patients with a current indication of narcotic use
- Individuals unable to provide informed consent:
- Prisoners
- Pregnant women
- Minors/Individuals under 18 years of age
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group 1 - Hip Arthroscopy
Will be prescribed 60 opiate tablets in addition to other routine post-operative pain medication regimens.
|
Will be prescribed 60 opiate tablets in addition to other routine post-operative pain medication regimens.
|
Active Comparator: Group 2 - Hip Arthroscopy
Will be prescribed 30 opiate tablets in addition to other routine post-operative pain medication regimens.
|
Will be prescribed 30 opiate tablets in addition to other routine post-operative pain medication regimens.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numeric Pain Rating Scale (NPRS) Pain Scores
Time Frame: Baseline (pre-operative)
|
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
|
Baseline (pre-operative)
|
Numeric Pain Rating Scale (NPRS) Pain Scores
Time Frame: 2 hours post-operative
|
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
|
2 hours post-operative
|
Numeric Pain Rating Scale (NPRS) Pain Scores
Time Frame: 24 hours post-operative
|
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
|
24 hours post-operative
|
Numeric Pain Rating Scale (NPRS) Pain Scores
Time Frame: 48 hours post-operative
|
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
|
48 hours post-operative
|
Numeric Pain Rating Scale (NPRS) Pain Scores
Time Frame: 7 days post-operative
|
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
|
7 days post-operative
|
Opiates Taken
Time Frame: 24 hours post-operative
|
Number of prescribed narcotic pills taken in the preceding time period
|
24 hours post-operative
|
Opiates Taken
Time Frame: 48 hours post-operative
|
Number of prescribed narcotic medication tablets taken in the preceding time period
|
48 hours post-operative
|
Opiates Taken
Time Frame: 7 days post-operative
|
Number of prescribed narcotic medication tablets taken in the preceding time period
|
7 days post-operative
|
Opiates Taken
Time Frame: 21 days post-operative
|
Number of prescribed narcotic medication tablets taken in the preceding time period
|
21 days post-operative
|
Opiates Remaining
Time Frame: 24 hours post-operative
|
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
|
24 hours post-operative
|
Opiates Remaining
Time Frame: 48 hours post-operative
|
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
|
48 hours post-operative
|
Opiates Remaining
Time Frame: 7 days post-operative
|
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
|
7 days post-operative
|
Opiates Remaining
Time Frame: 21 days post-operative
|
Number of prescribed narcotic medication tablets remaining from initial amount prescribed
|
21 days post-operative
|
Date of Last Opiate Taken
Time Frame: 21 days post-operative
|
Days following surgery that the most recent dose of narcotic medication was taken
|
21 days post-operative
|
Numeric Pain Rating Scale (NPRS) Pain Scores
Time Frame: 21 days
|
minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value indicates less pain reported by the patient
|
21 days
|
Number of Participants Reporting Side Effects
Time Frame: 24 hours postoperatively
|
As reported by patient.
Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, itchiness, nausea/vomiting
|
24 hours postoperatively
|
Number of Participants Reporting Side Effects
Time Frame: 48 hours postoperatively
|
As reported by patient.
Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, nausea/vomiting
|
48 hours postoperatively
|
Number of Participants Reporting Side Effects
Time Frame: 7 days postoperatively
|
As reported by patient.
Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, nausea/vomiting
|
7 days postoperatively
|
Number of Participants Reporting Side Effects
Time Frame: 21 days postoperatively
|
As reported by patient.
Including: blurred vision, confusion/mental fog, constipation, dizziness, drowsiness, nausea/vomiting
|
21 days postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00207356
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Injuries
-
Helse Stavanger HFRecruitingHip Fractures | Hip Injuries and DisordersNorway
-
FH ORTHORecruitingHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
-
Bayside HealthCompleted
-
University of LeedsCitieffe S.r.lUnknownUnilateral Unstable HipUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustCompletedHip Fractures | Fracture of Hip | Fractured HipUnited Kingdom
-
The University of Hong KongRecruiting
-
Mayo ClinicCompletedPertrochanteric Hip FractureUnited States
-
Eurofarma Laboratorios S.A.TerminatedHip Fracture SurgeryBrazil
Clinical Trials on Group 1 - Opiate Tablets post Hip Arthroscopy
-
Northwestern UniversityCompletedKnee Injuries | ACL InjuryUnited States
-
Massachusetts General HospitalActive, not recruitingAcetabular Labrum Tear | Osteoarthritis, Hip | Physical Therapy | Femoro Acetabular Impingement | Hip ArthroscopyUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA); Centers for Disease Control and Prevention and other collaboratorsCompleted
-
Tasly Pharmaceutical Group Co., LtdCompleted
-
University Health Network, TorontoCompleted
-
Ain Shams UniversityUnknownInduction of OvulationEgypt
-
University of TennesseeWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCovanceCompletedHealthy Adult SubjectsUnited States